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Dietary Salt Intake and Hypertension
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Over the past century, salt has been the subject of intense scientific research 
related to blood pressure elevation and cardiovascular mortalities. Moderate re-
duction of dietary salt intake is generally an effective measure to reduce blood 
pressure. However, recently some in the academic society and lay media dis-
pute the benefits of salt restriction, pointing to inconsistent outcomes noted in 
some observational studies. A reduction in dietary salt from the current intake 
of 9-12 g/day to the recommended level of less than 5-6 g/day will have major 
beneficial effects on cardiovascular health along with major healthcare cost 
savings around the world. The World Health Organization (WHO) strongly rec-
ommended to reduce dietary salt intake as one of the top priority actions to 
tackle the global non-communicable disease crisis and has urged member na-
tions to take action to reduce population wide dietary salt intake to decrease 
the number of deaths from hypertension, cardiovascular disease and stroke. 
However, some scientists still advocate the possibility of increased risk of CVD 
morbidity and mortality at extremes of low salt intake. Future research may in-
form the optimal sodium reduction strategies and intake targets for general 
populations. Until then, we have to continue to build consensus around the grea- 
test benefits of salt reduction for CVD prevention, and dietary salt intake reduc-
tion strategies must remain at the top of the public health agenda.
Key Words: Dietary salt, Restriction, Target, Hypertension
Received: June 13, 2014
Accepted: June 17, 2014
Corresponding Author: Sung Kyu Ha, M.D., Ph.D. 
Renal Division, Department of Internal Medicine, 
Gangnam Severance Hospital, Yonsei University 
College of Medicine, Seoul, Korea
Tel: +82-2-2019-3313, Fax: +82-2-3463-3882
E-mail: hask1951@yuhs.ac
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction
Recently, there has been a hot debate over whether cur-
rent salt intake is too high from a health perspective. It 
is estimated that globally 62% of cerebrovascular disease 
and 49% of ischaemic heart disease were attributable to 
elevated blood pressure. A technical report produced by 
WHO and the Food and Agriculture Organization of the 
United Nations recommended the consumption of less than 
5 g of salt per day as a population nutrient intake goal. 
Given the adverse impact of excessive salt consumption on 
health and particularly on blood pressure levels and car-
diovascular diseases, the World Health Organiztion has 
urged member nations to take action to reduce population 
wide dietary salt intake to decrease the number of deaths 
from hypertension, cardiovascular disease and stroke (WHO 
report 2006)1). Salt is an ionic compound composed of so-
dium chloride, which is 40% sodium and 60% chloride. 
Salt crystals are translucent and cubic in shape, they nor-
mally appear white. The molar mass of salt is 58.443g/mol, 
its melting point is 801℃(1,474℉) and its boiling point 
1,465℃(2,669℉). Salt is readily soluble in water and dis-
solved in water it separates into Na+ and Cl- ions. Over 
the past century, sodium chloride has been the subject of 
intense scientific research related to blood pressure (BP) ele-
vation and cardiovascular mortalities. However, recently 
some in the academic society and lay media dispute the 
benefits of salt restriction, pointing to inconsistent out-
comes noted in some observational studies2,3).
Brief history of Salt
For millions of years, human beings ate very small amo- 
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unts of salt (0.1-0.5 g/day). Among the food that humans 
ingest, meat has the highest salt content (about 0.6g of salt 
per pound). During the hunter-gathering period, the main 
food for human being was meat. Their diet consisted of 
50% meat and 50% plants. So the intake of salt in paleo-
lithic times was less than 1 g/day. In the mean times, pop-
ulation growth led to the introduction of agriculture, and 
during the first few thousand years after the advent of agri-
culture, the intake of meat declined and the intake of vege-
tables increased up to 90%. In the agricultural period, hu-
man beings consumed about the same amount of salt as 
did their hunter-gathering ancestors4). The earliest evidences 
of salt processing dates back to around 6,000 years ago. 
People living in Romania were boiling the salt-laden spring 
water to extract the salts. The harvest of salt from the sur-
face of Xiechi Lake near Yuncheng in Shanxi, China, dates 
back to at least 6000 BC, making it one of the oldest verifi-
able saltworks5). Salt was required as a food preservative 
for thousands of years. About 5,000 years ago, the Chinese 
discovered that salt could be used to preserve food. Salt 
then became of great economic importance as it was possi-
ble to preserve food during the winter and allowed the 
development of settled communities. With the increased 
use of salt, salt became a precious commodity of commerce. 
About 1,000 years ago, salt intake in the western world 
had risen to about 5 g/day6). Herodotus, an ancient Greek 
historian, described salt trading routes that united the salt 
oases of the Libyan desert back in the 5th century BC. In 
the early years of the Roman Empire, roads such as the 
Via Salaria were built for the transportation of salt from 
the salt pans of Ostia to the capital7). With the spread of 
civilization, salt became one of the world’s main trading 
commodities. Much of the food they ate contained salt and 
its consumption was increasing consequently. The oppressive 
salt tax in France was one of the causes of the French Re- 
volution. In India, this tax gave rise to a civil disobedience 
campaign under Mahatma Ghandi against the British8).
Salt and Human living
Salt is an essential electrolyte to life in human beings 
and is used universally in cooking, seasoning, and preser- 
ving manufactured food stuffs around the world. For sev-
eral million years, human ancestors ate a diet that con-
tained less than 1 g of salt per day. Salt was the most 
taxed and traded commodity in the world, with intake 
reaching a peak around the 19th century9). However, salt 
was no longer required as a food preservative with the 
invention of the refrigerator. Salt intake had been declin-
ing, but with the recently large increase in the consumption 
of highly salted processed food, salt intake is increasing 
towards levels similar to those of the 19th century, and 
is approximately 9-12 g/day in most countries around the 
world10). Most table salt sold for consumption contains 
additives. The amounts of additives vary widely from co- 
untry to country. Iodine is an important micronutrient 
for humans and iodized table salt has significantly re-
duced disorders of iodine deficiency. Salt is present in 
most foods we eat. However, in naturally occurring foods 
such as meats, vegetables, and fruits, salt is present in 
small quantities. There is more salt in animal tissues such 
as meat, blood and milk, than there is in plant tissues11). 
Nomads hunted and ate the meat within a few hours 
of the kill. They do not eat salt with their food, but agri-
culturalists, feeding mainly on cereals and vegetables, need 
to supplement their diet with salt12). Recently many proce- 
ssed foods use large amounts of salt and over 75% of daily 
sodium intake comes from salt found in processed foods.
Salt intake, Blood pressure, and Human health
Sodium serves as an important nutrient in the body 
and helps nerves and muscles to function correctly. It 
is also involved in the auto-regulation of the water and 
fluid balance of the body. High dietary salt intake presents 
a major challenge to the kidneys to excrete large amounts 
of salt administered. One of the main organ systems vul-
nerable to the adverse effects of excessive sodium in the 
diet is the cardiovascular system. Excess dietary sodium 
predisposes to high BP13,14). Changes in salt intake are 
associated in general with corresponding changes in arte-
rial BP. The earliest comment relating dietary salt intake 
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to BP was by the Chinese medical doctor in 2698-2598 
BC(Huang Ti Nei Ching Su Wen; The Yellow Emperor’s 
Classic of Internal Medicine): “therefore if large amounts 
of salt are taken, the pulse will stiffen or harden”15). The 
association between salt intake in the diet and BP was 
first suggested by Ambard and Beaujard in 190416). They 
studied 6 patients with high BP for 3 weeks. They used 
three kinds of salt and protein content of diets. Salt intake 
was measured by estimating the salt content of the food 
and the urine each day. When the diet contained little 
salt, the patients went into negative sodium balance and 
blood pressure fell, even though the intake of protein 
was raised. Conversely, when the diet was high in salt, 
less salt was excreted in the urine so that the patient was 
in positive sodium balance and the BP rose even when 
the protein intake was low. They concluded that it was 
the salt that primarily affected BP. They had some success 
in reducing BP by restricting salt intake.
In 1948, Kempner introduced rice diets for the treat-
ment of hypertension. He treated 500 hypertensive pa-
tients with a diet containing 20 g of protein, little fat, 
and <0.5 g salt. It mainly consisted of rice and fruit. He 
showed that rice diets containing little salt improved BP, 
decreased heart size, reversed inverted T waves in the 
EKG, and ameliorated hypertensive retinopathy. How- 
ever, a rice diet did not have widespread acceptability 
because of insipid and unpalatable features of food con- 
tents. The connection between high salt intake and eleva- 
ted BP became widely recognized after Kempner’s rice 
diet in 1948 and thus, high BP was lowered by a low salt 
diet and a renewed salt restriction strategy utilized in the 
treatment of hypertension17). Since then, many animal stu- 
dies showed a causal relationship between dietary sodium 
and hypertension and in human studies, established that 
the average BP in the population is related to habitual 
salt intake13). The available data in animal studies confirm 
the existing relationship between habitual salt intake and 
BP levels. A well-documented connection between hyper-
tension and dietary salt intake has been demonstrated in 
various animals, especially in rats and chimpanzees. Ball 
and Meneely18) reported that in groups of young adult 
rats that were fed different amounts of salt in their diet 
(0.15, 2.8, 5.6, 7.8, or 9.8%) with free access to distilled 
water, the average BP after 9 month increased proportio- 
nally to the amount of salt in their diet. A similar study 
had been performed in chimpanzees, which are genet-
ically very close to humans, by Denton et al.19). Chimpan- 
zees normally consume a diet low in salt, but when their 
salt intake increased to ~15 g/day for 20 months, they 
developed hypertension. The rise in BP was gradual and 
it was still rising 18 months after they started the high 
salt diet. Moreover, when the salt was reduced from the 
diet containing ~15g salt/day to 0.5g salt/day, blood pres-
sure levels fell back to the original level after 6 months. 
In this study, we can see a progressive increase in BP 
with added salt and this was completely reversible when 
the added salt was stopped. Experiments in chimpanzees 
strongly suggest that essential hypertension is due to high 
salt intake.
Studies on the effect of salt intake on BP in humans 
have been carried out extensively for the past several deca- 
des. After Kempner’s rice diet in 1948, other investigators 
showed the BP lowering effect of a low salt diet20). Howe- 
ver, it was a very difficult thing to reduce the salt intake 
below 1 g/day in the everyday food intakes in humans. 
Regional differences in habitual salt intake and BP within 
a population have been studied in various areas of the 
world. Around the Newfoundland area, a survey of salt 
intake revealed that a county in the center of the island 
had a typical salt intake varying between 6.7 and 7.3
g/day. In contrast, the salt intake varied between 8.4 and 
8.8 g/day in a relatively isolated coastal community21). 
This difference in salt intake was accompanied by parallel 
changes in the incidence of hypertension. In individuals 
aged between 55 and 75 years, the incidence of hyperten- 
sion in the inland community was 15% while it was 27% 
in the coastal community. Similar evidence had been ob-
tained among the Solomon Islanders22). In those tribes, 
which lived away from the coast and had a salt intake 
below 2 g/day, only 1% of the population had a raised 
BP. In two tribes with salt intakes between 3 and 8 g/day, 
3% of the population had a raised BP. In one tribe, which 
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lived on the coast and had a salt intake between 9 and 
15g/day, 8% of the population had a raised BP. Migratory 
studies also provide evidences of a relationship between 
habitual salt intake and BP. Studies of population groups 
that migrated from areas with lower salt intake to areas 
with higher salt intake have reported increases in BP. A 
carefully controlled study from Kenya showed that the 
migrants who had higher mean urinary sodium/potassium 
ratio compared to the non-migrants had higher systolic 
BP23). Blood pressure in these migrants rose after a few 
months (6.9/6.2 mmHg for systolic and diastolic), where-
as it did not increase in a control group who did not mi- 
grate24). Another example of the effect of life-style changes 
including dietary sodium intake on BP is that of the Yi 
people, an ethnic minority living in southwestern China. 
Blood pressure rose very little with increasing age (0.13 
and 0.23 mmHg/year for systolic and diastolic, respec- 
tively) in the Yi farmers who lived in a remote mountain-
ous environment and consumed a sodium-poor diet. In 
contrast, Yi migrants and Han people who lived in urban 
areas consumed a sodium-rich diet and experienced a 
much greater increase in BP with progressive aging (0.33 
and 0.33 mmHg/year for systolic and diastolic, respec- 
tively)25). These findings suggest that changes in life-style, 
including higher intake of dietary sodium, contributed 
to higher BP among Yi migrants.
A large number of epidemiologic, evolutionary, and 
clinical studies have confirmed that salt intake is an im-
portant factor in elevating the BP in humans. The first 
double-blind controlled study of moderate salt restriction 
was performed in the early 1980’s by MacGregor et al.26). 
They recruited nineteen unselected patients with mild to 
moderate essential hypertension, whose average supine 
BP after two months’ observation and no treatment was 
156/98 mmHg. Patients were advised to reduce dietary salt 
intake. After 2 weeks of sodium restriction, patients were 
entered into an 8-week double-blind randomized cross-
over study of ‘Slow Sodium’ (Ciba, 10 mmol of sodium 
per tablet) versus slow sodium placebo. The mean supine 
BP was 7.1 mmHg (6.1%) lower in the fourth week of 
slow sodium placebo than that in the fourth week of slow 
sodium Ciba (p<0.001). Urinary sodium excretion in the 
fourth week of slow sodium Ciba was 162±9 mmol/24 
hours and that in the fourth week of slow sodium placebo 
was 86±9 mmol/24 hours (p<0.001). They suggested that 
moderate sodium restriction should become part of the 
management of essential hypertension. Followed by this 
study, many large observational and epidemiological inve- 
stigations conducted worldwide link between high salt 
intake and hypertension.
INTERSALT study was one of the first large interna-
tional epidemiologic studies on sodium intake and hyper-
tension using a standardized method for measuring 24- 
hour urinary sodium. This study, which was a crosssec-
tional assessment of 10,079 subjects aged 20-59 sampled 
from 52 centers around the world, attempted to relate 
sodium intake to BP from an epidemiological perspective. 
Sodium excretion ranged from 0.2 mmol/24 hours (Yano- 
mamo Indians, Brazil) to 242 mmol/24 hour (north China). 
In individual subjects (within centers), salt intake was sig-
nificantly related to BP. Four centers found very low so-
dium excretion, low BP, and little or no upward slope 
of BP with age. Across the other 48 centers sodium was 
significantly related to the slope of BP with age but not 
to median BP. The study demonstrated a significant pos-
itive relationship between salt intake and BP in indivi- 
dual subjects within centers. In an initial analysis of 48 
of the 52 centers, no significant association between so-
dium intake and median BP was found. However, after 
inclusion of the remaining 4 centers, in which the average 
sodium consumption was 0.2-50 mmol/day, they found 
a significant association between salt intake and the increase 
in BP with age. Furthermore, it also found that populations 
with low average daily salt intakes had low BP and very 
little or no increase in BP with age27). INTERSALT study 
indicates that BP increases with age only if accompanied 
by increased salt intake. As part of the INTERSALT study, 
BP, urinary electrolytes, age, and body mass index were 
assessed in a sample of 195 Yanomamo Indians from the 
Brazilian Amazon28). Mean sodium excretion was 0.9mmol/ 
day. Urinary sodium was lower than 1 mmol/day in 84% 
of participants. Mean BP was 96.0/60.6 mmHg (range 
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78/37 to 128/86). Systolic and diastolic BP were not high-
er at older than at younger ages in men. In women, systolic 
pressure was lower at older ages. In this tribe, there was 
a low average population BP, no hypertension and no 
positive slope of BP with age in a population with very 
low salt intake. Salt institute criticized that in an initial 
analysis of 48 of the 52 centers, no significant association 
was noted between sodium intake and median BP. How- 
ever, the INTERSALT’s investigators re-analyzed their 
data and showed that the highly significant within-popula- 
tion association between salt intake and BP across all 52 
centers was virtually unchanged. Lowering sodium intake 
by 100 mmol was associated with a 3 mmHg decrease in 
systolic BP29).
There are several studies on the effect of reducing the 
salt intake on BP on a community levels. Forte et al.30) 
studied reducing the dietary salt intake on BP on a com-
munity in Portugal, which is notorious for its high con-
sumption of salt. The trial was performed in two com-
munities within the same district, each with 800 inhabi- 
tants who had salt intakes of ~21 g/day and a 30% in-
cidence of hypertension. In the intervention community, 
there was a widespread health education effort to reduce 
the dietary salt intake. The reduction in salt intake in 
one of the communities to ~12 g/day was associated with 
a highly significant difference in BP. By the end of the 
second year, there was a small rise in systolic BP in the 
control community and a significant fall in both systolic 
and diastolic BP in the low salt intake community, the 
difference between the two villages reached 13/6 mmHg. 
The fall in BP involved the whole community, normo-
tensives and hypertensive individuals alike, and the re-
sponse did not differ between the young and the old or 
between men and women. Those with the greatest fall 
in salt excretion tended significantly to be also those who 
showed the greatest fall in BP. The other long-term trial 
was carried out in Tianjin in China as part of a commun-
ity-based intervention program to reduce non-communi-
cable diseases31). This intervention was based on examina-
tions of independent cross-sectional population samples 
in 1989 (1,719 persons) and 1992 (2,304 persons) in the 
intervention and matched reference areas. The food recall 
method was used to measure dietary salt intake. The 
mean reduction in salt intake was 1.3 g/day in men and 
0.7 g/day in women in the intervention area from 1989 
to 1992. During the same period, the sodium intake in-
creased significantly in men of the reference area. The 
reduction was statistically significant in men (p<0.001) 
and near significant in women (p<0.05). In the inter-
vention area, the mean systolic BP decreased by 3 mmHg 
for the total population and by 2 mmHg for normotensive 
people. The decrease in systolic BP was significant for 
both hypertensive and normotensive subjects. Another 
long-term trial was performed in two Belgian towns of 
12,000 and 8,000 inhabitants, situated within 50 km of 
each other32). The low-sodium intervention in one town 
was mainly directed at women and implemented through 
mass media techniques, while the control town was merely 
observed. Cross-sectional random sampling at baseline 
and 5 years later was employed, the participation rate 
being similar (67%) in the two towns. During the study 
a total of 2,211 subjects were examined. In adult women 
(greater than or equal to 20 years) in the intervention town 
the 24-hour urinary excretion of sodium (UVNa) decrea- 
sed by 25 mmol/24 h (p<0.001) and this reduction dif-
fered (p=0.01) from the concurrent trend in UVNa in 
the control town (+8 mmol/24 h). However, both systolic 
BP (-7.5 versus -7.9 mmHg) and diastolic BP (-2.3 versus 
-3.0 mmHg) declined to a similar extent in the women 
from the two towns. In adult men in the intervention 
town, decreases were observed in UVNa (-12 mmol/24 h) 
and in systolic BP (-5.6 mmHg) and diastolic BP (-2.4 
mmHg), but these trends were not significantly different 
from the concurrent changes in the control town (-14 
mmol/24 h, -4.9 and +0.2 mmHg, respectively). No signi- 
ficant difference was observed in the evolution of mean 
systolic and diastolic pressures that declined to the same 
extent in the two towns during the trial. In women of the 
intervention town, 24-hour urinary salt excretion decre- 
ased by 1.5 g, whereas in the control town it rose by 
0.5 g. This negative result may be explained by the small 
reduction in salt consumption that would be insufficient 
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to observe a net effect on BP in the Belgian environment. 
These results suggest that a reduction in salt consumption 
is difficult to achieve with mass media techniques and in 
women and in subjects aged 50 years or more, the inter-
vention did achieve some success, but BP was not affected.
There were many randomized clinical trials performed 
to test the effects of reducing salt intake on BP. Cutler 
et al.33) analyzed previously published randomized clinical 
trials testing the effects of reducing sodium intake on BP. 
Thirty-two trials with outcome data for 2,635 subjects 
were included. Pooled BP differences between treated and 
control groups were highly significant for all trials com- 
bined. The effects on blood pressure by lowering sodium 
in hypertensive and normotensive subjects were -4.8/-2.5 
and -1.9/-1.1 mmHg (systolic/diastolic), respectively. Me- 
dian differences in sodium excretion between sodium-re-
duction and control groups in these subgroups were -77 
and -76 mmol/24 h, respectively. Weighted linear-regre- 
ssion analyses across the trials showed dose responses, 
which were more consistent for trials in normotensive 
subjects. These analyses yielded estimates, per 100 mmol 
of sodium reduction, of -5.8/-2.5 mmHg in hypertensive 
subjects and -2.3/-1.4 mmHg in normotensive subjects, 
respectively. There is no evidence that sodium reduction 
as achieved in these trials presents any safety hazards. 
They concluded that the BP reduction with a substantial 
lowering of dietary sodium in the US population could 
reduce cardiovascular morbidity and mortality. However, 
in two other meta-analyses34,35), it was claimed that salt 
reduction had very little effect on BP in individuals with 
normal BP and a reduction in population salt intake was 
not warranted. The meta-analysis by Midgley et al.34) in-
cluded 56 trials that had randomized allocation to control 
and dietary sodium intervention groups with outcome 
measures of both systolic and diastolic BP. The mean redu- 
ction in daily urinary sodium excretion was 95 mmol/ 
day (71-119 mmol/day) in 28 trials with 1,131 hyperten- 
sive subjects and 125 mmol/day (95-156 mmol/day) in 28 
trials with 2,374 normotensive subjects. The decrease in 
BP for a 100 mmol/day reduction in daily sodium excre- 
tion was 3.7 mmHg (2.35-5.05 mmHg) for systolic (p< 
0.001) and 0.9 mmHg (-0.13 to 1.85 mmHg) for diastolic 
(p=0.09) in the hypertensive subjects, and 1.0mmHg (0.51  
-1.56 mmHg) for systolic (p<0.001) and 0.1 mmHg(-0.32 
to 0.51 mmHg) for diastolic (p=0.64) in the normotensive 
subjects. Decreases in BP were larger in trials of older hy-
pertensive individuals and small and non-significant in 
trials of normotensive individuals. They concluded that 
dietary sodium restriction for older hypertensive indivi- 
duals might be considered, but the evidence in the normo-
tensive population does not support current recommenda- 
tions for universal dietary sodium restriction. Another 
meta-analysis by Graudal et al.35) included 58 trials of 
hypertensive and 56 trials of normotensive person to eva- 
luate the effect of sodium restriction to blood pressure 
lowering. In 58 trials of hypertensive subjects, the effect 
of reduced sodium intake as measured by urinary sodium 
excretion (mean, 118 mmol/24 h) on systolic BP was 3.9 
mmHg (p<0.001) and on diastolic BP was 1.9 mmHg (p 
<0.001). In 56 trials of normotensive subjects, the effect 
of reduced sodium intake (mean, 160 mmol/24 h) on sys-
tolic BP was 1.2 mmHg (p<0.001) and on diastolic BP 
was 0.26 mmHg (p=0.12). They concluded that these re-
sults do not support a general recommendation to reduce 
sodium intake. However, these two meta-analyses were 
criticized by some authors because the data included was 
flawed. Both meta-analysis included trials of very short 
duration with comparing the effects of acute salt loading 
to abrupt and severe salt restriction for only a few days. 
It is inappropriate to include the acute salt restriction 
trials in a meta-analysis where the implications of the 
findings are to apply them to public health recommenda- 
tions for a long-term. It is possible that acute and large 
reduction in salt intake increases sympathetic activity, sti- 
mulates the renin-angiotensin system which would coun-
teract the effects on BP.
Subsequently, several large-scale intervention studies 
showing significant antihypertensive effects of salt reduc-
tion in diet were performed by several groups. Trials of 
Hypertension Prevention (TOHP) phases I and II were 
two large randomized controlled trials enrolling 2,182 
and 2,382 patients, respectively. In TOHP I36), the patients 
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were randomized to three life-style change groups (weight 
reduction, sodium reduction, and stress management), 
one of which was a low sodium diet. At 18 months fol-
low-up, weight reduction intervention produced weight 
loss of 3.9 kg (p<0.01), diastolic BP change of -2.3 mmHg 
(p<0.01), and systolic BP change of -2.9 mmHg (p<0.01). 
Sodium reduction interventions also lowered urinary so-
dium excretion by 44 mmol/24 hours (p<0.01), diastolic 
BP by 0.9 mmHg (p<0.05), and systolic BP by 1.7 mmHg 
(p<0.01). They concluded that weight reduction was the 
most effective strategy tested for reducing BP in normo-
tensive persons. Sodium reduction was also effective for 
reducing BP. In TOHP II37), from baseline, participants' 
sodium excretion decreased 50 and 40 mmol/day at 6 and 
36 months in the sodium reduction group, respectively. 
Compared with the usual care group, BP decreased 2.9/ 
1.6 mmHg in the sodium reduction group, and 4.0/2.8 
mmHg in the combined group (weight and sodium reduc-
tion) at 6 months (all groups, p<0.001). At 36 months, 
BP decreases remained greater in the active intervention 
groups than in the usual care group (weight loss group, 
1.3/0.9 mmHg; sodium reduction group, 1.2/0.7 mmHg; 
combined group, 1.1/0.6 mmHg). Differences were stat-
istically significant for systolic BP in the sodium reduction 
group. The long-term, 10- to 15-year Trials of Hyperten- 
sion Prevention (TOHP) I and II show that, apart from lo- 
wering BP, net sodium reduction by 44mmol/day (TOHP I) 
and 33 mmol/day (TOPH II) leads to significant reduction 
in cardiovascular events by 25%, even after adjustment 
for several confounding factors. TOPH I and II will pre-
sumably remain the best evidence supporting the benefi-
cial effect of a moderate reduction of salt intake in the 
general population38).
The intervention studies of salt intake reduction are 
often conducted with other life-style modifications. TONE 
study39) was performed to determine whether weight loss 
or reduced sodium intake is effective in the treatment of 
older persons (aged 60 to 80 years) with hypertension. 
The authors randomized 585 obese participants to reduced 
sodium intake, weight loss, both, or usual care, and the 
390 non-obese participants to reduced sodium intake or 
usual care. The primary endpoint included high blood 
pressure after discontinuation of the BP lowering medi-
cation at entry (190/110, 170/100, and 150/90 mmHg at 
1, 2, 3 visits-not adjudicated), resuming drug treatment, 
inability to withdraw treatment, and cardiovascular com-
plications (angina, myocardial infarction, stroke, heart 
failure, and coronary revascularization). After a median 
follow-up of 29 months (range 15-36 months), the com-
posite outcome occurred less frequently among those as-
signed vs. not allocated to reduced sodium intake (hazard 
ratio 0.69; 95% CI, 0.59-0.81; p<0.001). The mean 
change in blood pressure for participants assigned to so-
dium reduction alone was -3.4 mmHg systolic and -1.9 
mmHg diastolic, and for participants assigned to com-
bined intervention of sodium reduction and weight loss 
-5.3 mmHg systolic and -3.4 mmHg diastolic, respectively 
(p<0.001 for comparisons to usual care group). This study, 
however, has to be interpreted with caution including se- 
lection of adherent and well educated patients (only 11.1% 
of pre-screened patients were finally randomized) and un-
certain blinding. There was no difference between sodium- 
restricted and control patients in the incidence of cardio- 
vascular events (44 [12.9%] versus 57 [16.7%]; p=0.24). 
TONE study showed significant antihypertensive effects 
of salt reduction in diet. The level of salt restriction effec-
tive for maintaining a normal BP after the discontinuation 
of an antihypertensive drug was -5.6 g per day or less. 
TONE study demonstrated that a reduced sodium intake 
and weight loss, alone or combined, could effectively 
control hypertension39).
Another well-conducted landmark study was the DASH 
(Dietary Approaches to Stop Hypertension)-Sodium trial40), 
a 12-week well controlled feeding trial provided the most 
robust evidence about the effect of salt intake on human 
BP. It was a multi-centered clinical trial that studied three 
levels of sodium intake (150, 100 and 50 mmol/day) on 
412 individuals with and without hyper- tension. Each 
intake of salt was maintained for 30 days. Two different 
diets that is the control diet and the DASH diet, which 
is rich in fruits, vegetables and low-fat dairy products, 
were tested. In both groups, the participants were assig- 
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ned randomly to a high sodium diet (150 mmol/ d), nor-
mal sodium diet (100 mmol/d), or low sodium diet (50
mmol/d) for 30 days and were then crossed over within 
their assigned groups. When the participants were shifted 
from a high sodium diet to a normal sodium diet, the 
systolic BP decreased by 2.1 mmHg (p<0.001) in the 
control group and by 1.3 mmHg (p=0.03) in the DASH 
group. When they were shifted from a normal sodium 
diet to a low sodium diet, there was a further reduction 
in systolic BP of 4.6mmHg in the control group(p<0.001) 
and 1.7 mmHg in the DASH group (p<0.01). When com- 
pared with the controls, the DASH diet led to a lower 
systolic BP of 7.1 mmHg in participants without hyper-
tension and 11.5 mmHg in participants with hypertension. 
The adherence to the diet of participants was monitored, 
not only by measuring 24-hour urine sodium at the end 
of each period but also their daily food diaries. The study 
demonstrated that a reduction in salt intake lowered BP 
both on the control diet and on the DASH diet. The 
combination of a low salt and  DASH diet had a greater 
effect on BP than either intervention alone. There was 
a very significant difference in systolic (-6.7 mmHg) and 
diastolic pressure (-3.5 mmHg) between participants on 
the 150 mmol sodium/day diet and those on the 50 mmol 
sodium/day. The blood pressures were all significantly 
lower on the DASH diet. There was a greater reduction 
in systolic pressure when blood pressure was initially high 
and in women, but most importantly the blood pressure- 
lowering effect of reducing the salt intake was observed 
in all categories of the population, in particular in normo-
tensive as well as in hypertensive people. The DASH-so-
dium trial supports that a low sodium diet leads to lower 
blood pressure. This observation is very important for 
the public health issue of lowering salt intake. Most ac-
knowledge that this study reliably confirmed the benefit 
of dietary sodium restriction in BP management. However, 
the DASH diet was significantly different from the con-
trol diet in terms of more fruits, vegetables, low-fat dairy 
foods, fish, nuts, potassium, calcium, magnesium, and di-
etary fiber. Although the group on the DASH diet had 
a lower urinary sodium excretion, this does not necessa-
rily imply that the benefit was being solely caused by 
a dietary sodium reduction. In addition, this study did 
not evaluate the long-term effects of the intervention and 
the clinically relevant variables, such as mortality or mor- 
bidity. After the DASH-Sodium trial, many meta-analyses 
of intervention studies were investigated. In 2002, He 
and MacGregor41) demonstrated that a modest salt intake 
reduction caused significant falls in BP in both hyper-
tensive and normotensive individuals. In this study, a to-
tal of 17 trials in hypertensives (n=734) and 11 trials 
in normotensives (n=2,220) were included. The median 
reduction in 24-hour urinary sodium excretion was 78 
mmol in hypertensives and 74 mmol in normotensives. 
The pooled estimates of BP fall were 4.96/2.73±0.40/ 
0.24 mmHg in hypertensives (p<0.001) and 2.03/0.97± 
0.27/0.21 mmHg in normotensives (p<0.001). Weighted 
linear regression analyses showed a dose response rela-
tionship between the change in urinary sodium and BP. 
A reduction of 100 mmol/day in salt intake predicted a 
fall in BP of 7.11/3.88 mmHg (p<0.001) in hypertensives 
and 3.57/1.66 mmHg in normotensive individuals (p< 
0.05). They demonstrated that a modest reduction in salt 
intake for a duration of 4 or more weeks does have a sig- 
nificant and important effect on BP in both hypertensive 
and normotensive individuals. These findings in conjunc- 
tion with other previous evidence relating salt intake to 
BP make a strong case for a reduction in population salt 
intake, which will lower population BP and therefore re-
duce cardiovascular mortality. Many meta-analyses, so 
far, on the effect of salt reduction on BP have shown 
consistent reductions in BP in those with high blood pres-
sure, but there has been some controversy about the mag-
nitude of the fall in BP in normotensive individuals34,36). 
In these two meta-analyses, it was claimed that salt reduc-
tion had no or very little effect on blood pressure in nor-
motensive individuals. However, detailed examination of 
these two meta-analyses showed that their data collection 
and analysis were flawed.
Recently, there has been a hot debate whether current 
salt intake is too high from a health perspective. There 
were studies reporting the influence of salt intake on 
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overall cardiovascular diseases such as He et al. (obese 
subjects)42) and Tuomilehto et al.43). They suggested that 
salt reduction prevented the onset of cardiovascular dis- 
eases. He et al.42) estimated that reduction of salt intake 
by 3 g per day lowered systolic blood pressure by 5.6 
mmHg in hypertensive individuals. They also found that 
it was the obese and not the non-obese who benefited. 
Tuomilehto et al.43) prospectively followed 1,173 Finnish 
men and 1,263 women aged 25-64 years with complete 
data on 24 hour urinary sodium excretion and cardiovas- 
cular risk factors. The hazards ratios for coronary heart 
disease, cardiovascular disease, and all-cause mortality, 
associated with a 100 mmol increase in 24 hour urinary 
sodium excretion, were 1.51 (95% CI 1.14-2.00), 1.45 
(1.14-1.84), and 1.26 (1.06-1.50), respectively, in both 
men and women. The frequency of acute coronary events 
rose significantly with increasing sodium excretion. They 
concluded that high sodium intake predicted mortality 
and risk of coronary heart disease, independent of other 
cardiovascular risk factors, including blood pressure. In 
a study by O’Donnell et al.44), the tendency of an exce- 
ssive salt intake-induced increase in the incidence of car-
diovascular diseases was also observed. Strazzullo et al.45) 
also performed a meta-analysis of prospective cohort stu- 
dies and reported that excessive salt consumption tended 
to increase the incidence of cardiovascular diseases. There- 
fore, a salt reduction strategy may be a useful tool for 
preventing cardiovascular diseases. However, to the con-
trary, Alderman et al.46) and Cohen et al.47) repeatedly 
suggested that excessive salt reduction increased the in-
cidence of cardiovascular diseases. In the presidential ad-
dress of the 21st International Society of Hypertension 
meeting in 2007, Alderman48) advocated that the relation-
ship between salt intake and the risk of cardiovascular 
diseases is J-shaped and that salt intake at 5 to 6 g per 
day might be characterized by the lowest risk of cardiovas- 
cular diseases. In 2011, Stolarz-Skrzypeket al.49) reported 
prospective longitudinal population-based study including 
3,681 people without cardiovascular disease at baseline. 
During a median follow up of 7.9 years, cardiovascular 
deaths decreased across increasing tertiles of 24-hour so-
dium excretion. This significant inverse association be-
tween cardiovascular mortality and tertile of sodium ex-
cretion was retained in multivariable analyses (p=0.02), 
with a HR(Harzard Ratio) of 1.56 in the low tertile versus 
the overall risk in the whole study population (p=0.04). 
The 24-hour sodium excretion at baseline did not predict 
either total mortality or fatal combined with nonfatal car-
diovascular events. In a subgroup of 1,499 participants 
who had both BP and sodium excretion measured at base-
line and at last follow-up were followed up for a median 
of 6.1 years. The annual increases in BP averaged 0.37 
mmHg systolic and 0.47 mmHg diastolic (p<0.001), but 
on average the 24-hour urinary sodium excretion did not 
change over time. However, in multivariable-adjusted 
analyses of individual participants, a 100-mmol increment 
in 24-hour sodium excretion was associated with a signifi- 
cant 1.71 mmHg increase in systolic BP (p<0.001), with-
out concomitant change in diastolic BP. They concluded 
that lower urinary sodium excretion was associated with 
higher cardiovascular disease (CVD) mortality. These fin- 
dings contradict a large body of evidence that established 
elevated salt consumption as a risk factor for CVD. How- 
ever, many researchers including He et al.50) criticize the 
results of this study. In the same year, Taylor et al.51) 
published the results of a meta-analysis of intervention 
studies regarding salt reduction. This meta-analysis in-
volved randomized, control studies of salt reduction in 
which follow-up was continued for >6 months; three 
of these studies involved normotensive individuals, two 
hypertensive patients and one normotensive and hyper-
tensive combined subjects. Of these, hypertensive and nor- 
motensive individuals were separately analyzed. Salt re-
duction was associated with reductions in urinary salt ex-
cretion of between 27 and 39mmol per 24hour and reduc- 
tions in systolic blood pressure between 1 and 4 mmHg. 
Pooled relative risks (RRs) comparing the intervention 
with the reference groups for all-cause mortality were 
0.90 (CI, 0.58-1.40; 79 deaths) and 0.96 (CI, 0.83-1.11; 
565 deaths) in normotensive and hypertensive participants, 
respectively. Salt restriction increased the risk of all-cause 
mortality in patients with heart failure (RR, 2.59; CI, 1.04- 
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6.44; 21 deaths). In both hypertensive and normotensive 
individuals, salt reduction slightly decreased the incidence 
of cardiovascular diseases, although there was no signifi- 
cant difference. These authors found no strong evidence 
that salt reduction reduced all-cause mortality or CVD 
morbidity in normotensives or hypertensives. A single RCT 
showed an increase in the risk of all-cause death in those 
with congestive heart failure receiving a low-sodium diet. 
In contrast, He et al.52) simultaneously analyzed normo-
tensive individuals and hypertensive patients from the 
same studies including Taylor’s meta-analysis. They repor- 
ted that salt reduction at 2.0 to 2.3 g per day signifi- 
cantly decreased the risk of cardiovascular diseases (20% 
of decrease). However, in most studies supporting the fact 
that salt reduction increases the risk of cardiovascular dis-
eases, methodological problems have been indicated47,49), 
or study subjects were high-risk patients46,51).
In conclusion, a moderate reduction of dietary salt in-
take is generally an effective measure to reduce blood 
pressure. A reduction in dietary salt from the current in-
take of 9-12 g/day to the recommended level of less than 
5-6 g/day will have major beneficial effects on cardiovas- 
cular health along with major healthcare cost savings aro- 
und the world. The WHO strongly recommended to reduce 
dietary salt intake as one of the top priority actions to 
tackle the global non-communicable disease crisis and has 
urged member nations to take action to reduce popula- 
tion wide dietary salt intake to decrease the number of 
deaths from hypertension, cardiovascular disease and 
stroke. However, some scientists still advocate the possi-
bility of increased risk of CVD morbidity and mortality 
at extremes of low salt intake. Future research may in-
form aspects of optimal sodium reduction strategies and 
the intake targets for populations. Until then, we have 
to continue to build consensus around the greatest bene-
fits of salt reduction for CVD prevention, and dietary 
salt intake reduction strategies must remain at the top of 
the public health agenda.
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